JoVE Logo
Faculty Resource Center

Sign In

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

DOI :

10.3791/63744-v

May 12th, 2023

May 12th, 2023

761 Views

1Department of Biology, University of Pisa, 2General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa

Preclinical models aim to advance the knowledge of cancer biology and predict treatment efficacy. This paper describes the generation of zebrafish-based patient-derived xenografts (zPDXs) with tumor tissue fragments. The zPDXs were treated with chemotherapy, the therapeutic effect of which was assessed in terms of cell apoptosis of the transplanted tissue.

-- Views

Related Videos

article

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

article

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

article

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

article

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

article

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

article

Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models

article

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

article

Enhanced Viability for Ex vivo 3D Hydrogel Cultures of Patient-Derived Xenografts in a Perfused Microfluidic Platform

article

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish

article

The Establishment and Utilization of Patient Derived Xenograft Models of Central Nervous System Metastasis

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved